A detailed history of Profund Advisors LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 156,167 shares of OCGN stock, worth $120,248. This represents 0.01% of its overall portfolio holdings.

Number of Shares
156,167
Previous 146,642 6.5%
Holding current value
$120,248
Previous $227,000 32.16%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.98 - $1.95 $9,334 - $18,573
9,525 Added 6.5%
156,167 $154,000
Q2 2024

Aug 13, 2024

BUY
$1.18 - $1.98 $173,037 - $290,351
146,642 New
146,642 $227,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $167M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.